These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 26487586)

  • 1. Comprehensive serum cytokine analysis identifies IL-1RA and soluble IL-2Rα as predictors of event-free survival in T-cell lymphoma.
    Gupta M; Stenson M; O'Byrne M; Maurer MJ; Habermann T; Cerhan JR; Weiner GW; Witzig TE
    Ann Oncol; 2016 Jan; 27(1):165-72. PubMed ID: 26487586
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevated soluble IL-2Rα, IL-8, and MIP-1β levels are associated with inferior outcome and are independent of MIPI score in patients with mantle cell lymphoma.
    Sonbol MB; Maurer MJ; Stenson MJ; Allmer C; LaPlant BR; Weiner GJ; Macon WR; Cerhan JR; Witzig TE; Gupta M
    Am J Hematol; 2014 Dec; 89(12):E223-7. PubMed ID: 25164110
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytokine and cytokine receptor serum levels in adult bone sarcoma patients: correlations with local tumor extent and prognosis.
    Rutkowski P; Kamińska J; Kowalska M; Ruka W; Steffen J
    J Surg Oncol; 2003 Nov; 84(3):151-9. PubMed ID: 14598359
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum soluble interleukin 2 receptor alpha in human cancer of adults and children: a review.
    Bien E; Balcerska A
    Biomarkers; 2008 Feb; 13(1):1-26. PubMed ID: 17906988
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical significance of serum soluble interleukin-2 receptor-α in extranodal natural killer/T-cell lymphoma (ENKTL): a predictive biomarker for treatment efficacy and valuable prognostic factor.
    Wang L; Liao DZ; Zhang J; Xia ZJ; Peng XW; Lu Y
    Med Oncol; 2013 Dec; 30(4):723. PubMed ID: 24037346
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic importance of the soluble form of IL-2 receptorα (sIL-2Rα) and its relationship with surface expression of IL-2Rα (CD25) of lymphoma cells in diffuse large B-cell lymphoma treated with CHOP-like regimen with or without rituximab: a retrospective analysis of 338 cases.
    Hashimoto Y; Yokohama A; Saitoh A; Nakahashi H; Toyama K; Mitsui T; Koiso H; Saitoh T; Handa H; Uchiumi H; Jinbo T; Murayama K; Matsumoto M; Sawamura M; Karasawa M; Murakami H; Hirato J; Nojima Y; Kojima M; Tsukamoto N
    J Clin Exp Hematop; 2013; 53(3):197-205. PubMed ID: 24369221
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating interleukin (IL)-8, IL-2R, IL-12, and IL-15 levels are independently prognostic in primary myelofibrosis: a comprehensive cytokine profiling study.
    Tefferi A; Vaidya R; Caramazza D; Finke C; Lasho T; Pardanani A
    J Clin Oncol; 2011 Apr; 29(10):1356-63. PubMed ID: 21300928
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elevated serum monoclonal and polyclonal free light chains and interferon inducible protein-10 predicts inferior prognosis in untreated diffuse large B-cell lymphoma.
    Witzig TE; Maurer MJ; Stenson MJ; Allmer C; Macon W; Link B; Katzmann JA; Gupta M
    Am J Hematol; 2014 Apr; 89(4):417-22. PubMed ID: 24382707
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical relevance of elevated levels of serum soluble interleukin-2 receptor alpha (sIL-2Rα) in patients with non-Hodgkin's lymphoma.
    Jo SA; Hwang SH; Chang CL; Kim SY; Shin HJ; Chung JS; Sol MY; Lee EY
    Korean J Lab Med; 2010 Dec; 30(6):600-5. PubMed ID: 21157146
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Soluble IL-2Rα facilitates IL-2-mediated immune responses and predicts reduced survival in follicular B-cell non-Hodgkin lymphoma.
    Yang ZZ; Grote DM; Ziesmer SC; Manske MK; Witzig TE; Novak AJ; Ansell SM
    Blood; 2011 Sep; 118(10):2809-20. PubMed ID: 21719603
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ultra-high level of serum soluble interleukin-2 receptor at diagnosis predicts poor outcome for angioimmunoblastic T-cell lymphoma.
    Shiratori S; Kosugi-Kanaya M; Shigematsu A; Kobayashi H; Yamamoto S; Kobayashi N; Iwasaki H; Mori A; Kunieda Y; Yutaka T; Kurosawa M; Kakinoki Y; Endo T; Kondo T; Hashino S; Teshima T;
    Leuk Lymphoma; 2015; 56(9):2592-7. PubMed ID: 25563559
    [TBL] [Abstract][Full Text] [Related]  

  • 12. sTREM-1, sIL-2Rα, and IL-6, but not sCD163, might predict sepsis in polytrauma patients: a prospective cohort study.
    Trancă S; Oever JT; Ciuce C; Netea M; Slavcovici A; Petrișor C; Hagău N
    Eur J Trauma Emerg Surg; 2017 Jun; 43(3):363-370. PubMed ID: 27169526
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Soluble interleukin-2 receptor and metalloproteinase-9 expression in head and neck cancer: prognostic value and analysis of their relationships.
    El Houda Agueznay N; Badoual C; Hans S; Gey A; Vingert B; Peyrard S; Quintin-Colonna F; Ravel P; Bruneval P; Roncelin S; Lelongt B; Bertoglio J; Fridman WH; Brasnu D; Tartour E
    Clin Exp Immunol; 2007 Oct; 150(1):114-23. PubMed ID: 17680822
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Soluble interleukin-2 receptor α activation in a Children's Oncology Group randomized trial of interleukin-2 therapy for pediatric acute myeloid leukemia.
    Lange BJ; Yang RK; Gan J; Hank JA; Sievers EL; Alonzo TA; Gerbing RB; Sondel PM
    Pediatr Blood Cancer; 2011 Sep; 57(3):398-405. PubMed ID: 21681921
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical significance of serum soluble interleukin 2 receptor-alpha in esophageal squamous cell carcinoma.
    Wang LS; Chow KC; Li WY; Liu CC; Wu YC; Huang MH
    Clin Cancer Res; 2000 Apr; 6(4):1445-51. PubMed ID: 10778976
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Soluble IL-2Rα correlates with imbalances of Th1/Th2 and Tc1/Tc2 cells in patients with acute brucellosis.
    Sun HL; Ma CJ; Du XF; Yang SY; Lv X; Zhao H; Wang LH; Tang YX; Li XW; Jiang RM
    Infect Dis Poverty; 2020 Jul; 9(1):92. PubMed ID: 32660627
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum level of soluble interleukin-2 receptor alpha correlates with the clinical course and activity of Wilms' tumour and soft tissue sarcomas in children.
    Bien E; Balcerska A; Kuchta G
    Biomarkers; 2007; 12(2):203-13. PubMed ID: 17536769
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic significance of pretreatment serum cytokines in classical Hodgkin lymphoma.
    Marri PR; Hodge LS; Maurer MJ; Ziesmer SC; Slager SL; Habermann TM; Link BK; Cerhan JR; Novak AJ; Ansell SM
    Clin Cancer Res; 2013 Dec; 19(24):6812-9. PubMed ID: 24141626
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High Level of Serum Soluble Interleukin-2 Receptor Is Associated With Poor Survival in Patients With First Relapsed or Refractory Peripheral T-Cell Lymphoma, Not Otherwise Specified: A Retrospective Study.
    Morita-Fujita M; Katoh D; Shimomura Y; Ishikawa T
    Clin Lymphoma Myeloma Leuk; 2019 Jul; 19(7):e337-e342. PubMed ID: 31053551
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interleukin 6, soluble interleukin 2 receptor alpha (CD25), monocyte colony-stimulating factor, and hepatocyte growth factor linked with systemic hyperinflammation, innate immunity hyperactivation, and organ damage in COVID-19 pneumonia.
    Quartuccio L; Fabris M; Sonaglia A; Peghin M; Domenis R; Cifù A; Curcio F; Tascini C
    Cytokine; 2021 Apr; 140():155438. PubMed ID: 33493861
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.